Madden Martin J. 4
4 · NovoCure Ltd · Filed Jun 6, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+33,393→ 33,393 totalExercise: $16.72From: 2026-06-04Exp: 2035-06-04→ Ordinary Shares (33,393 underlying)
Footnotes (1)
- [F1]Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders.